Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Hiromatsu

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Ryoikibetsu Shokogun Shirizu|October 13, 2001
[Myasthenia gravis associated with Graves' disease]Y Hiromatsu
Ryoikibetsu Shokogun Shirizu|October 13, 2001
[Thyrotoxic myopathy]Y Hiromatsu
Ryoikibetsu Shokogun Shirizu|October 13, 2001
[Hypothyroid myopathy]I Miyake, Y Hiromatsu
Ryoikibetsu Shokogun Shirizu|October 13, 2001
[Thyrotoxic periodic paralysis]I Miyake, Y Hiromatsu
Endocrinology and Metabolism Clinics of North America|June 1, 1987
Cytotoxic mechanisms in autoimmune thyroid disorders and thyroid-associated ophthalmopathyY Hiromatsu, H Fukazawa, J R Wall
Clinical Endocrinology|January 1, 1992
Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cellsY Hiromatsu, M Sato, K Yamada, et al.
European Journal of Nuclear Medicine|November 18, 1998
Technetium-99m tetrofosmin imaging in patients with subacute thyroiditisY Hiromatsu, M Ishibashi, I Miyake, et al.
Immunology Letters|January 1, 1992
Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cellsY Hiromatsu, M Sato, K Yamada, et al.
Clinical and Experimental Immunology|December 1, 1987
Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cellsY Hiromatsu, H Fukazawa, J How, et al.
Autoimmunity|January 1, 1990
Significance of cytotoxic eye muscle antibodies in patients with thyroid-associated ophthalmopathyY Hiromatsu, L Cadarso, M Salvi, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Ryoikibetsu Shokogun Shirizu|October 13, 2001
[Myasthenia gravis associated with Graves' disease]Y Hiromatsu
Ryoikibetsu Shokogun Shirizu|October 13, 2001
[Thyrotoxic myopathy]Y Hiromatsu
Ryoikibetsu Shokogun Shirizu|October 13, 2001
[Hypothyroid myopathy]I Miyake, Y Hiromatsu
Ryoikibetsu Shokogun Shirizu|October 13, 2001
[Thyrotoxic periodic paralysis]I Miyake, Y Hiromatsu
Endocrinology and Metabolism Clinics of North America|June 1, 1987
Cytotoxic mechanisms in autoimmune thyroid disorders and thyroid-associated ophthalmopathyY Hiromatsu, H Fukazawa, J R Wall
Clinical Endocrinology|January 1, 1992
Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cellsY Hiromatsu, M Sato, K Yamada, et al.
European Journal of Nuclear Medicine|November 18, 1998
Technetium-99m tetrofosmin imaging in patients with subacute thyroiditisY Hiromatsu, M Ishibashi, I Miyake, et al.
Immunology Letters|January 1, 1992
Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cellsY Hiromatsu, M Sato, K Yamada, et al.
Clinical and Experimental Immunology|December 1, 1987
Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cellsY Hiromatsu, H Fukazawa, J How, et al.
Autoimmunity|January 1, 1990
Significance of cytotoxic eye muscle antibodies in patients with thyroid-associated ophthalmopathyY Hiromatsu, L Cadarso, M Salvi, et al.
Pageof 6